ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000266999.1	ABT-263 (navitoclax)	Sarcoma	0.047515454	Resistant
ENSG00000266999.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.025379561	Sensitive